The Journal
Regulation, quality, process, and access — written for clients who prefer clarity over promises.
Latest
How Much Does a Peptide Consultation Pathway Cost in Australia? One of the most common questions people ask when researching this space is simple: what does it actually cost? The answer depends on the type of pathway, the level of practitioner involvement, and what’s included in the service — thi…
18 July 2026
18 July 2026
Compounded Peptides vs Online Sources: What to Know. A sourcing and quality-assurance comparison between the licensed compounding pathway and unregulated online sellers, including plain ARTG status.
18 July 2026
Peptide Quality in Australia: Purity Testing, Heavy Metal Screening, and What to Look For As interest in peptide-related telehealth consultations continues to grow across Australia, many people ask a practical question: how are compounded peptide preparations tested, and what should a person unde…
18 July 2026
Peptides in Australia: Understanding Schedule 4 (Prescription-Only) Medicines As interest in peptides grows across Australia, many people want clarity on how these substances are actually regulated. One important concept is Schedule 4 (S4) — the prescription-only category under Australia’s Poison…
18 July 2026
Are Peptides Legal in Australia? Understanding Regulation and Access “Are peptides legal in Australia?” is one of the most common questions people ask. The honest answer isn’t a simple yes or no — it depends on the specific peptide, how it’s classified under the Poisons Standard, and how it’s acc…
18 July 2026
BPC-157 and TB-500 are frequently searched substance names. This is a general regulatory reference on their status in Australia — not a description of uses, effects or benefits. General information only.
12 July 2026
AOD-9604 Explained: What the Research Says and Its ARTG Status AOD-9604 has a distinctive history among peptides, having originated from Australian research and undergone formal clinical trials. This article covers what class of substance it is, its research history, and how it’s regulated in Aus…
12 July 2026
Sermorelin Explained: What It Is and How It’s Regulated in Australia Sermorelin is a synthetic peptide with a longer history than many others discussed in this space, including past approved use overseas. This article covers what class of substance it is, its research history, and how it’s regula…
12 July 2026
MK-677 Explained: What It Is and How It’s Regulated in Australia MK-677 is a synthetic compound frequently discussed alongside growth-hormone-pathway peptides, though it is chemically distinct from a peptide. This article covers what class of substance it is, its research history, and how it’s re…
12 July 2026
KPV Explained: What It Is and How It’s Regulated in Australia KPV is a short peptide sequence that has drawn research and public interest. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes only. What Is …
12 July 2026
IGF-1 LR3 Explained: What It Is and How It’s Regulated in Australia IGF-1 LR3 is a modified, long-acting synthetic analogue of a naturally occurring growth factor. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educationa…
12 July 2026
Selank Explained: Origins, Research, and Australian Regulation Selank is a synthetic peptide originally developed in Russia. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes only. What Is Selank? Selank…
12 July 2026
Semax Explained: Origins, Research, and Australian Regulation Semax is a synthetic peptide, also originally developed in Russia, often discussed alongside Selank. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational…
12 July 2026
PT-141: What It Is and How It’s Regulated in Australia PT-141 (Bremelanotide) is a peptide that holds approval from some overseas regulators for a specific indication. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educat…
12 July 2026
DSIP Explained: What It Is and How It’s Regulated in Australia DSIP (Delta Sleep-Inducing Peptide) is a peptide first identified several decades ago. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes onl…
12 July 2026
IGF-1 LR3 Explained: What It Is and How It’s Regulated in Australia IGF-1 LR3 is a modified, long-acting synthetic analogue of a naturally occurring growth factor. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educationa…
12 July 2026
NAD+ is a molecule t NAD+ Explained: What It Is and How It’s Regulated in Australia NAD+ is a substance that has attracted significant public interest, including in IV therapy and compounding contexts. This article covers what class of substance it is and how it’s regulated in Australia — for gene…
12 July 2026
hCG Explained: What It Is and How It’s Regulated in Australia hCG (human chorionic gonadotropin) is different from most other substances discussed in this series — it is a naturally occurring hormone with genuine, long-standing approved medical uses in Australia for specific indications. This art…
12 July 2026
GLP-1 medicines are a class of prescription-only medicines that have attracted significant public interest in recent years. This article covers what the class is, how it’s regulated in Australia, and an important distinction between approved and compounded versions — for general educational purposes only. …
12 July 2026
AOD-9604 Explained: What the Research Says and Its ARTG Status AOD-9604 has a distinctive history among peptides, having originated from Australian research and undergone formal clinical trials. This article covers what class of substance it is, its research history, and how it’s regulated in Aus…
12 July 2026
PT-141: What It Is and How It’s Regulated in Australia PT-141 (Bremelanotide) is a peptide that holds approval from some overseas regulators for a specific indication. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educat…
12 July 2026
Epitalon Explained: Origins, Research, and Australian Regulation Epitalon (also spelled Epithalon) is a synthetic peptide with a research history originating largely in Russian scientific literature. This article covers what class of substance it is, its research history, and how it’s regulated i…
12 July 2026
Tesamorelin: What It Is and Its Regulatory Status in Australia Tesamorelin is a peptide that, unlike some others in this space, holds approval from some overseas regulators for a specific indication. This article covers what class of substance it is, its research history, and how it’s regulated i…
12 July 2026
CJC-1295 and Ipamorelin Explained: What They Are and How They’re Regulated CJC-1295 and Ipamorelin are two distinct peptides that are frequently discussed together. This article covers what class of substances they are, their research history, and how they’re regulated in Australia — for general …
12 July 2026
GHK-Cu: What It Is and How It’s Classified in Australia GHK-Cu is a copper-binding peptide that occurs naturally and is also used as an ingredient in some cosmetic products. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general …
12 July 2026
Thymosin Beta-4 Explained: What the Research Says and How It’s Regulated Thymosin Beta-4 is a peptide that occurs naturally and has also attracted research interest as a synthetic compound. This article covers what class of substance it is, its research history, and how it’s regulated in Australi…
12 July 2026
Thymosin Alpha-1: What It Is and Its ARTG Status in Australia Thymosin Alpha-1 is a peptide with a longer research history than many others discussed in this space. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general education…
12 July 2026
MOTS-c Explained: Origins, Research, and Australian Regulation MOTS-c is a substance that has been the subject of academic research. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes only. What Is MO…
12 July 2026
BPC-157: What It Is and How It’s Regulated in Australia BPC-157 is one of the peptides most frequently discussed online and in research contexts. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes only. W…
11 July 2026
Perimenopause and Menopause: What the Research Actually Says Perimenopause and menopause are widely discussed but often poorly understood transitions. This article looks at what published research says about symptoms, lifestyle interventions, and management approaches. What Is Perimenopause? Peri…
11 July 2026
Healthy Ageing: What the Research Actually Says “Healthy ageing” is a widely used phrase, but what does research actually say contributes to it? This article looks at findings from published systematic reviews on physical activity, nutrition, and frailty in the context of ageing. Physical Activit…
11 July 2026
Understanding Sleep: What the Research Actually Says Sleep is one of the most researched areas of health science, yet many common beliefs about it are oversimplified. This article looks at what current research actually shows about sleep duration, regularity, and healthy sleep habits. Sleep Durat…
10 July 2026
How consultation coordination works for Melbourne and Victoria: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support afterwards.
10 July 2026
How consultation coordination works for Sydney and New South Wales: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support afterwards.
10 July 2026
How consultation coordination works for Perth and Western Australia: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support afterwards.
10 July 2026
How consultation coordination works for the Gold Coast and Australia-wide: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support.
7 July 2026
A plain explanation of how a telehealth consultation pathway is coordinated in Australia, and the role independent registered medical practitioners and licensed pharmacies play.
4 July 2026
How telehealth consultation coordination works across Sydney, Melbourne, Brisbane, the Gold Coast, Perth and Adelaide, and what an independent practitioner assessment involves.
4 July 2026
An outline of consultation coordination Australia-wide: how enquiries are handled, what an independent telehealth assessment involves, and where administrative support fits in.
4 July 2026
An explanation of how consultation and assessment pathways are structured in Australia, and why suitability is determined solely by an independent registered medical practitioner.
4 July 2026
How coordinated telehealth consultations are arranged in major Australian cities, and what administrative support looks like before and after an independent practitioner assessment.
4 July 2026
What to expect from a coordinated telehealth consultation in Australia — from initial enquiry through to independent practitioner assessment and ongoing administrative coordination.
23 June 2026
How consultation and prescription pathways work in Australia: an enquiry, an independent telehealth assessment, and where administrative coordination fits in. Any prescribing decision rests solely with the practitioner.
23 June 2026
How consultation coordination works for Darwin residents: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support afterwards. Any prescribing decision rests solely with the practitioner.
4 May 2026
Telehealth Consultation Coordination for Gold Coast Residents If you live on the Gold Coast and you’re researching peptide-related healthcare pathways, one of the first things worth understanding is that this isn’t a walk-in clinic service — it’s a telehealth-based process, and knowing how t…
2 May 2026
How consultation coordination works across Sydney, Melbourne and Australia-wide: an enquiry, an independent telehealth consultation with a an independent, registered healthcare practitioner, and administrative support.
2 May 2026
Telehealth Peptide Consultation Coordination Across Queensland GL Vitality Drips coordinates telehealth consultations with independent, registered healthcare practitioners for individuals across Queensland — including Brisbane, the Gold Coast, and the Sunshine Coast. Since access runs through tel…
26 April 2026
Peptides Near Me: How Nationwide Telehealth Access Works in Australia Many people searching for “peptides near me” are expecting to find a local clinic. In Australia, that’s generally not how this space works — most legitimate pathways run through telehealth rather than an in-person clinic visit.…
22 April 2026
How telehealth consultation pathways are structured and regulated in Australia, and where administrative coordination fits in. Any clinical decision rests solely with the practitioner.
20 April 2026
Are Peptides Legal in Australia? Understanding Regulation and Access “Are peptides legal in Australia?” is one of the most common questions people ask. The honest answer isn’t a simple yes or no — it depends on the specific peptide, how it’s classified under the Poisons Standard, and how it’s acc…
20 April 2026
How consultation coordination works across Brisbane and South East Queensland: enquiry, independent telehealth consultation with a an independent, registered healthcare practitioner, and ongoing administrative coordination.
13 April 2026
How Much Does a Peptide Consultation Pathway Cost in Australia? One of the most common questions people ask when researching this space is simple: what does it actually cost? The answer depends on the type of pathway, the level of practitioner involvement, and what’s included in the service — thi…
6 April 2026
How to Evaluate a Telehealth Peptide Consultation Service in Australia Choosing between telehealth services in this space can be confusing, particularly with a growing number of options online. This article looks at the factors that distinguish a properly regulated, practitioner-led pathway from …
4 April 2026
PeptidesPeptides in Australia: Understanding Schedule 4 (Prescription-Only) Medicines As interest in peptides grows across Australia, many people want clarity on how these substances are actually regulated. One important concept is Schedule 4 (S4) — the prescription-only category under Australia’…
4 April 2026
Understanding Peptide Sourcing and Compounding in Australia Many people researching peptides in Australia want to understand how quality, sourcing, and preparation actually work — and how that differs from products sold online outside any regulated pathway. This article looks at how compounded pe…
4 April 2026
Compounded Peptides vs Online Sources: What to Know. A sourcing and quality-assurance comparison between the licensed compounding pathway and unregulated online sellers, including plain ARTG status.
4 April 2026
Are Peptides Legal in Australia? Understanding the Regulatory Framework Many people ask a version of the same question: are peptides legal in Australia? The honest answer is that it depends on the specific peptide, since legal status in Australia is determined individually under the Poisons Stand…
Journal
Quiet notes on preventative wellness, integrative care and concierge coordination.